A new two-center study provides support for the use of intravenous dexamethasone in patients with acute hemorrhagic stroke—a treatment strategy that is employed routinely at the University Hospital of Heraklion, Crete but has not been widely adopted elsewhere. Patients with acute hemorrhagic stroke who were treated in Heraklion (391 cases, 341 of whom received intravenous dexamethasone) had better outcomes than those treated at Massachusetts General Hospital, Boston, USA (510 cases, none of whom received corticosteroids).